In addition, regarding its contribution to post-stroke neuroplastic changes [8], [10], strategies aiming at upregulating mature BDNF levels or mimicking BDNF signaling may offer clinically relevant therapeutics. The gene discussed is BDNF; the disease is stroke disorder.